Zhen Zhang

7510842, Mar 31, 2009

Mar 10, 2006

11/373833

Valdimir Podust - Fremont CA, US
Zhen Zhang - Dayton MD, US
Eric T. Fung - Los Altos CA, US
Robert Bast - Houston TX, US
Daniel W. Chan - Clarksville MD, US
Jin Song - Baltimore MD, US

Vermilllion, Inc. - Fremont CA
The John Hopkins University - Baltimore MD
Board of Regents, The University of Texas System - Austin TX

G01N 33/53

435 71, 435 723

The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.

8404589, Mar 26, 2013

Apr 6, 2010

12/754912

Andrew J. Kellock - Sunnyvale CA, US
Christian Lavoie - Pleasantville NY, US
Ahmet Ozcan - Pleasantville NY, US
Stephen Rossnagel - Pleasantville NY, US
Bin Yang - Ossining NY, US
Zhen Zhang - Ossining NY, US
Yu Zhu - West Harrison NY, US
Stefan Zollner - Hopewell Junction NY, US

International Business Machines Corporation - Armonk NY
Globalfoundries Inc.

H01L 21/44

438686, 438651, 438682, 438664, 438655, 257E21165

A method for forming a silicide contact includes depositing a metal layer on silicon such that the metal layer intermixes with the silicon to form an intermixed region on the silicon; removing an unintermixed portion of the metal layer from the intermixed region; and annealing the intermixed region to form a silicide contact on the silicon. A semiconductor device comprising a silicide contact located over a silicon layer of the semiconductor device, the silicide contact comprising nickel (Ni) and silicon (Si) and having Ni amount equivalent to a thickness of about 21 angstroms or less.

20100068724, Mar 18, 2010

Mar 9, 2009

12/381218

Eric T. Fung - Los Altos CA, US
Robert Bast - Houston TX, US
Daniel W. Chan - Clarksville MD, US
Jin Song - Baltimore MD, US
Valdimir Podust - Fremont CA, US
Zhen Zhang - Dayton MD, US

Vermilllion, Inc. - Fremont CA
The Johns Hopkins University - Baltimore MD
Board of Regents, The University of Texas System - Austin TX

G01N 33/53
G01N 33/543

435 71, 436518

The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying ovarian cancer status as well as endometrical cancer status in a patient. In particular, it has been found that hepcidin is a biomarker for both ovarian cancer and endometrial cancer and that a panel of biomarkers, including hepcidin, transthyretin and optionally other markers are useful to classify a subject sample as ovarian cancer or non-ovarian cancer. The biomarkers can be detected by SELDI mass spectrometry.